Search

There’s a war going on! Growth investors are proclaiming that Apple is done, kaput. It’s history. To a value investor, however, Apple shares are an irresistible bargain! Apple sells at a very reasonable 13 times earnings and pays a nice dividend yielding 1.9% annually. Further, Apple’s PEG ratio (current P/E divided by the forecast growth rate) is also very attractive at 0.86.

For investors, the Almanac tells us that October is the start of the period of the year that has historically had the best performance in the stock market.

As all experienced investors know, bull markets climb a wall of worry.

Apple’s new product announcement this week was a big deal. When a company’s market cap is hovering around $640 billion, its gross profit was $70.5 billion in the past year and its stock is held by 2,157 institutional investors, it can’t be anything but a big deal. But for any growth investors out there who have their eye on AAPL, I’ve got to ask, “What the heck are you thinking?”

There was an interesting coincidence in both our Wall Street Best Investments and Wall Street’s Best Dividend Stocks newsletters last month. Each of our Spotlight Stocks are preparing to spinoff into separate companies.

My contention today is that the last thing a growth investor needs to hear right now is someone predicting which way the market will move next. And the predictors are running wild.

The best indication that a company is prospering is its history of dividend payments.

Dover Corp. (DOV) and Family Dollar Stores (FDO) are blue chip companies that currently sell at attractive prices.

Standard & Poor’s lists a whopping 196 biotechnology companies in its database, but AbbVie (ABBV) stands out above the rest. The company is growing rapidly but due to the correction in biotech stocks, it’s now an undervalued stock.

Not all stocks are falling in this volatile market. The stock prices of leading companies operating in stable industries generally hold steady during market declines. I advise investing at least 50% of your portfolio into ultra-safe stocks and ETFs. I have assembled a list of 12 ultra-safe companies for your review.

One of the blue-chip stocks I have been recommending lately is a company that has been around for a long time.

Those of us who work the growth investing side of things here at Cabot certainly enjoy the stock selection process.

Mid-cap stocks are often overlooked, meaning many are undervalued. To find the best values, the first thing to look for is a low PEG ratio. Here’s how.

Amazon.com (AMZN) has completely changed the retail landscape, and it’s creating cheap investments along the way. Here are six that hold particular value.

A collection of some of our best advice from January through March 2011.

A look at the fourth quarter, October through December, when the market was anything but kind to investors.

Gildan Activewear and Silver Wheaton are both promising value stocks.

Al Frank’s Prudent Speculator has been the best undervalued stock newsletter over the past 40 years. In the last 20 years, my newsletter has beaten it.